Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients

Journal of Endocrinological Investigation

Volumn 22, Issue 5, 1999, Pages 333-339

  Longobardi, Salvatore ^a,b   Di Rella, F ^a   Pivonello, R ^a   Di Somma, C ^a   Klain, M ^a   Maurelli, L ^a   Scarpa, R ^a   Colao, A ^a   Merola, B ^a   Lombardi, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

Bone mass; Bone turnover; GH; GH deficiency; Osteopenia

Indexed keywords

COLLAGEN TYPE 3; CREATININE; DEOXYPYRIDINOLINE; GROWTH HORMONE; HYDROXYPROLINE; OSTEOCALCIN; PROCOLLAGEN C PROTEINASE; RECOMBINANT GROWTH HORMONE;

ADULT; ARTHRALGIA; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; FEMUR NECK; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYDROXYPROLINE URINE LEVEL; MALE; ONSET AGE; OSTEOLYSIS; SOFT TISSUE;

EID: 0033040752     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343570     Document Type: Article

References (30)

1. Cuneo R.C., Salomon F., McGauley GA, Sonksen P.H. The growth hormone deficiency syndrome in adults. Clin. Endocrinol. 1992, 37: 387-397.
2. Carrol P.V., Christ E.R., Bengtsson B.A., Carlsson L., Christiansen U.S., Clemmons D., Hintz R., Ho K., Laron Z., Sizonenko P., Sonksen P.H., Tanaka T., Thomer M. Growth hormone deficiency in adulthood and the effect of growth hormone replacement a review. J. Clin. Endocrinol. Metab. 1998, 83: 382-395.
3. Wuster C.H.R., Slenczka E., Ziegler R. Erhohte Pravalenz von Osteoporose und Arteriosklerose bei konventionell Substituierter Hypophysenvorderlappeninsuffizienz: befard einer zusatzlichen Wachstumshormonsubstitution? Klin. Wochensch. 1991, 69: 769-773.
4. Sartorio A., Ortolani S., Conti A., Cherubini R., Galbiati E., Faglia G. Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency. J. Endocrinol. Invest. 1996, 19: 524-529.
5. Kaufmann J.M., Taelman P., Vermeulen A., Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. Clin. Endocrinol. Metab. 1992, 74: 118-123.
6. Bravenboer N., Holzmann P., De Boer H., Blok G.J., Lips P. Histomorphometric analysis of bone mass and bone metabolism in growth hormone deficient adult men. Bone 1996, 8: 551-557.
7. Finkenstedt G., Gasser R.W., Hofle G., Watfah C., Fridrich L. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-bone placebo-controlled study with open follow-up. Eur. J. Endocrinol. 1997, 136: 282-289.
8. Holmes S.J., Shalet S.M. Adult growth hormone deficiency and bone mass. Horm. Res. 1996, 45: 69-71.
9. Balducci L., Toscano V., Pasquino A.M., Mangiantini A., Municchi G., Armenise P., Terracina S., Prossomariti G., Boscherini B. Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy. Eur. J. Endocrinol. 1995, 132: 42-46.
10. Amato G., Izzo G., La Montagna G., Bellastella A. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects. Clin. Endocrinol. 1996, 45: 27-32.
11. Stiegler C., Leb G. One year of replacement therapy in adults with growth hormone deficiency. Endocrinol. Metab. 1994, 1: 37-39.
12. Hansen T.B., Brixen K., Vahl N., Jorgensen J.O.L., Christiansen J.S., Mosekilde L., Hagen C. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. Clin. Endocrinol. Metab. 1996, 81: 3352-3356.
13. Holmes S.J., Whitehouse R.W., Swindell R., Economou G., Adams J.E., Shalet S.M. Effect of growth hormone replacement therapy on bone mass in adults with adult onset growth hormone deficiency. Clin. Endocrinol. 1995, 42: 627-633.
14. Rosen T., Johannsson G., Hallgren P., Caidhal K., Bosaeus I., Bengtsson B.A. Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinol. Metab. 1994, 1: 55-66.
15. Bollerslev J., Moller J., Thomas S., Djoseland O., Christiansen J.S. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency. Eur. J. Endocrinol. 1996, 135: 666-671.
16. Johannsson G., Bengtsson B-A. Growth hormone and the acquisition of bone mass. Horm. Res. 1997, 48: 72.
17. Beshyah S.A., Thomas E., Kyd P., Sharp P., Fairney A., Johnston D.G. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin. Endocrinol. 1994, 40: 383-391.
18. Vandeweghe M., Taelman P., Kaufmann J.M. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin. Endocrinol. 1993, 39: 409-415.
19. Rahim A., Holmes S.J., Adams J. E., Shalet S.M. Long-term change in bone mineral density of adult with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy. Clin. Endocrinol. 1998, 48: 463-489.
20. Longobardi S., Merola B., Pivonello R., Di Rella F., Di Somma C., Colao A., Ghigo E., Camanni F., Lombardi G. Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood. Clin. Endocrinol. Metab. 1996, 81: 1244-1247.
21. Eyre D.R. Collagen cross-linking aminoacids. In: Cunningham L.W. (Ed.), Methods in Enzimology. Academy Press, New York, 1987, vol. 44, p. 115.
22. Glastre C., Braillon P., David L., Cocht P., Meunier P.J., Delmas P.D. Measurement of bone mineral content in the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters. Clin. Endocrinol. Metab. 1990, 70: 1330-1333.
23. Ott S.M. Attainment of peak bone mass. Clin. Endocrinol. Metab. 1990, 71: 1082A-1082C.
24. Degerbald M., Bengtsson B.A., Bramnert M., Johnell O., Manhem P., Rosen T., Thoren M. Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy. Eur. J. Endocrinol. 1995, 133: 180-188.
25. Shore R.M., Chesney R.W., Mazess R.B., Rose P.G., Bargman G.J. Bone mineral status in growth hormone deficiency. J. Pedriatr. 1980, 96: 393-396.
26. O'Halloran D.J., Tsatsoulis A., Whitehouse R.W., Holmes S.J., Adams J.E., Shalet S.M. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. Clin. Endocrinol. Metab. 1993, 76: 1344-1348.
27. Binnerts A., Swart G.R., Wilson J.H.P., Hoogerbrugge N., Pols H.A.P., Birkenhager J.C., Lamberts S.W.J. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin. Endocrinol. 1992, 37: 79-87.
28. Whitehead H.M., Boreham C., McIlrath M.N., Sheridan B., Kennedy L., Atkinson A.B., Hadden D.R. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin. Endocrinol. 1992, 36: 45-52.
29. Johannsson G., Rosen T., Bosaeus I., Sjostrom L., Bengtsson B.A. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. Clin. Endocrinol. 1996, 81: 2865-2873.
30. De Boer H., Blok G.J., Van der Veen E.A. Clinical aspects of growth hormone deficiency in adults. Endocr. Rev. 1996, 16: 63-86.